Updated

Lawmakers from both parties, along with patients, have increasingly targeted pharmacy benefit managers (PBMs) over their role in drug pricing, with states like Tennessee and Arkansas moving to regulate them. The bipartisan consensus marks a rare point of political agreement on healthcare policy. The regulatory push reflects growing frustration with PBMs' influence over prescription drug costs and access, as states take matters into their own hands amid stalled federal action.